These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Subtypes of Parkinson's Disease: What Do They Tell Us About Disease Progression? Fereshtehnejad SM; Postuma RB Curr Neurol Neurosci Rep; 2017 Apr; 17(4):34. PubMed ID: 28324303 [TBL] [Abstract][Full Text] [Related]
3. Value of cerebrospinal fluid α-synuclein species as biomarker in Parkinson's diagnosis and prognosis. Parnetti L; Cicognola C; Eusebi P; Chiasserini D Biomark Med; 2016; 10(1):35-49. PubMed ID: 26643452 [TBL] [Abstract][Full Text] [Related]
4. Biomarkers in Parkinson's disease: an update. Shtilbans A; Henchcliffe C Curr Opin Neurol; 2012 Aug; 25(4):460-5. PubMed ID: 22772875 [TBL] [Abstract][Full Text] [Related]
5. Biomarkers and Parkinson's disease. Michell AW; Lewis SJ; Foltynie T; Barker RA Brain; 2004 Aug; 127(Pt 8):1693-705. PubMed ID: 15215212 [TBL] [Abstract][Full Text] [Related]
6. The search for biomarkers in Parkinson's disease: a critical review. Antoniades CA; Barker RA Expert Rev Neurother; 2008 Dec; 8(12):1841-52. PubMed ID: 19086880 [TBL] [Abstract][Full Text] [Related]
7. [Cerebrospinal fluid biomarkers for the early diagnosis of Parkinson's disease]. da Costa AG; Gago MF; Garrett C Acta Med Port; 2011 Dec; 24 Suppl 4():761-8. PubMed ID: 22863482 [TBL] [Abstract][Full Text] [Related]
8. Biomarkers in Parkinson's disease: Advances and strategies. Delenclos M; Jones DR; McLean PJ; Uitti RJ Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1(Suppl 1):S106-10. PubMed ID: 26439946 [TBL] [Abstract][Full Text] [Related]
9. Biomarkers for Parkinson's [corrected] disease: tools to assess Parkinson's disease onset and progression. Marek K; Jennings D; Tamagnan G; Seibyl J Ann Neurol; 2008 Dec; 64 Suppl 2():S111-21. PubMed ID: 19127587 [TBL] [Abstract][Full Text] [Related]
10. New markers in Parkinson's disease. Bougea A Adv Clin Chem; 2020; 96():137-178. PubMed ID: 32362317 [TBL] [Abstract][Full Text] [Related]
11. Non motor subtypes and Parkinson's disease. Sauerbier A; Jenner P; Todorova A; Chaudhuri KR Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S41-6. PubMed ID: 26459660 [TBL] [Abstract][Full Text] [Related]
12. [Enteric nervous system and Parkinson's disease]. Paillusson S; Lebouvier T; Pouclet H; Coron E; Bruley des Varannes S; Damier P; Neunlist M; Derkinderen P Rev Med Interne; 2012 Jun; 33(6):335-8. PubMed ID: 22318211 [TBL] [Abstract][Full Text] [Related]
13. Biomarkers for trials of neuroprotection in Parkinson's disease. Agarwal PA; Stoessl AJ Mov Disord; 2013 Jan; 28(1):71-85. PubMed ID: 22927101 [TBL] [Abstract][Full Text] [Related]
14. Development of Parkinson's disease biomarkers. Prakash KM; Tan EK Expert Rev Neurother; 2010 Dec; 10(12):1811-25. PubMed ID: 21091313 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic validity of biomarkers in Parkinson's Disease: systematic review and meta-analysis. Costa MFBNAD; Reisdorfer E; Kempfer SS; Fernandes GCM; Porporatti AL; Canto GL Rev Bras Enferm; 2018; 71(6):3074-3083. PubMed ID: 30517414 [TBL] [Abstract][Full Text] [Related]
16. New concepts in the early and preclinical detection of Parkinson's disease: therapeutic implications. Akhtar RS; Stern MB Expert Rev Neurother; 2012 Dec; 12(12):1429-38. PubMed ID: 23237350 [TBL] [Abstract][Full Text] [Related]